Search Results - "Gottenberg, J. E"

Schnitzler syndrome: validation and applicability of diagnostic criteria in real‐life patients by Gusdorf, L., Asli, B., Barbarot, S., Néel, A., Masseau, A., Puéchal, X., Gottenberg, J‐E., Grateau, G., Blanchard‐Delaunay, C., Rizzi, R., Lifermann, F., Kyndt, X., Aubin, F., Bessis, D., Boye, T., Gayet, S., Rongioletti, F., Sauleau, E., Fermand, J‐P., Lipsker, D.

“…Background Schnitzler syndrome is characterized by an urticarial rash, a monoclonal gammopathy, and clinical, histological, and biological signs of…”
Get full text

CXCL13 and CCL11 Serum Levels and Lymphoma and Disease Activity in Primary Sjögren's Syndrome by Nocturne, G., Seror, R., Fogel, O., Belkhir, R., Boudaoud, S., Saraux, A., Larroche, C., Le Guern, V., Gottenberg, J. E., Mariette, X.

“…Objective Non‐Hodgkin's lymphoma (NHL) is a severe complication of primary Sjögren's syndrome (SS). Ectopic germinal centers (GCs) in the salivary glands are…”
Get full text

Psoriatic arthritis with hyperuricemia: more peripheral, destructive, and challenging to treat by Widawski, L., Fabacher, T., Spielmann, L., Gottenberg, JE, Sibilia, J., Duret, PM, Messer, L., Felten, R.

“…Objective To study the impact of hyperuricemia on clinical presentation, severity, and associated comorbidities of psoriatic arthritis (PsA). Methods…”
Get full text

Brief Report: Association of Rheumatoid Factor and Anti–Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan‐European Registry Analysis by Gottenberg, J. E., Courvoisier, D. S., Hernandez, M. V., Iannone, F., Lie, E., Canhão, H., Pavelka, K., Hetland, M. L., Turesson, C., Mariette, X., Finckh, A.

“…Objective To investigate the role of rheumatoid factor (RF) status and anti–citrullinated peptide antibody (ACPA) status as predictors of abatacept (ABA)…”
Get full text

Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the 'Orencia and Rheumatoid Arthritis' registry by Gottenberg, J E, Ravaud, P, Cantagrel, A, Combe, B, Flipo, R M, Schaeverbeke, T, Houvenagel, E, Gaudin, P, Loeuille, D, Rist, S, Dougados, M, Sibilia, J, Le Loët, X, Marcelli, C, Bardin, T, Pane, I, Baron, G, Mariette, X

“…Very limited data are available regarding the efficacy of abatacept (ABA) in real life. The aims of this study were to determine the efficacy of ABA in…”
Get more information

Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases by Gottenberg, J-E, Guillevin, L, Lambotte, O, Combe, B, Allanore, Y, Cantagrel, A, Larroche, C, Soubrier, M, Bouillet, L, Dougados, M, Fain, O, Farge, D, Kyndt, X, Lortholary, O, Masson, C, Moura, B, Remy, P, Thomas, T, Wendling, D, Anaya, J-M, Sibilia, J, Mariette, X

“…Objective: To assess the tolerance and efficacy of rituximab in patients with various autoimmune diseases seen in daily rheumatological practice. Methods: 866…”
Get full text

Gammaglobulins, autoantibodies, therapeutic antibodies and anti‐drug antibodies in rheumatoid arthritis by Gottenberg, J.‐E.

Get full text

Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjögren’s syndrome by Gottenberg, J-E, Aucouturier, F, Goetz, J, Sordet, C, Jahn, I, Busson, M, Cayuela, J-M, Sibilia, J, Mariette, X

“…Background: B cell activation may result in an increased secretion of immunoglobulin free light chains (FLCs) in autoimmune diseases. Objective: To analyse…”
Get full text

Efficacy of rituximab in primary Sjogren's syndrome with peripheral nervous system involvement: results from the AIR registry by Mekinian, A, Ravaud, P, Hatron, P Y, Larroche, C, Leone, J, Gombert, B, Hamidou, M, Cantagrel, A, Marcelli, C, Rist, S, Breban, M, Launay, D, Fain, O, Gottenberg, J E, Mariette, X

“…To evaluate rituximab (RTX) in primary Sjögren's syndrome (pSS) with peripheral nervous system (PNS) involvement. Patients with pSS and PNS involvement who…”
Get more information

B-cell Activating Factor of the Tumour Necrosis Factor Family Expression in Blood Monocytes and T Cells from Patients with Primary Sjögren's Syndrome by Lavie, F, Miceli-Richard, C, Ittah, M, Sellam, J, Gottenberg, J.-E, Mariette, X

“…We investigated B-cell activating factor of the tumour necrosis factor family (BAFF) level in peripheral blood mononuclear cells (PBMCs), monocytes and T cells…”
Get full text

STAT4 is a confirmed genetic risk factor for Sjögren's syndrome and could be involved in type 1 interferon pathway signaling by Gestermann, N, Mekinian, A, Comets, E, Loiseau, P, Puechal, X, Hachulla, E, Gottenberg, J-E, Mariette, X, Miceli-Richard, C

“…Signal transducer and activator of transcription 4 (STAT4) is a transcription factor mainly activated by interleukin 12, which promotes the secretion of type 2…”
Get full text

Safety of Surgery After Rituximab Therapy in 133 Patients With Rheumatoid Arthritis: Data From the AutoImmunity and Rituximab Registry by Godot, S., Gottenberg, J.‐E., Paternotte, S., Pane, I., Combe, B., Sibilia, J., Flipo, R.‐M., Schaeverbeke, T., Ravaud, P., Toussirot, E., Berenbaum, F., Mariette, X., Wendling, D., Sellam, J.

“…Objective We used data from the AutoImmunity and Rituximab (AIR) registry to investigate the safety of surgery for patients with rheumatoid arthritis receiving…”
Get full text

Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: Data from the French Autoimmunity and Rituximab registry by Terrier, B., Launay, D., Kaplanski, G., Hot, A., Larroche, C., Cathébras, P., Combe, B., de Jaureguiberry, J. P., Meyer, O., Schaeverbeke, T., Somogyi, A., Tricot, L., Zénone, T., Ravaud, P., Gottenberg, J. E., Mariette, X., Cacoub, P.

“…Objective Management of nonviral cryoglobulinemia vasculitis has yet to be defined. Rituximab has emerged as a novel and promising therapeutic alternative, but…”
Get full text

Primary Sjögren's syndrome: Pathophysiological, clinical and therapeutic advances by Gottenberg, J.-E

“…Abstract Primary Sjögren's syndrome was long a vexing dilemma, as the underlying pathophysiological mechanisms remained obscure, disease activity was…”
Get full text

Quantitative assessment of antibodies to ribonucleoproteins in primary Sjögren syndrome: correlation with B-cell biomarkers and disease activity by Candon, S, Gottenberg, J E, Bengoufa, D, Chatenoud, L, Mariette, X

“…To assess the added value of using a radioligand assay (RLA) compared with ELISA to detect antibodies to SSA, SSB and RNP, and to analyse the correlation…”
Get more information

European League Against Rheumatism Sjögren's Syndrome Disease Activity Index and European League Against Rheumatism Sjögren's Syndrome Patient‐Reported Index: A Complete Picture of Primary Sjögren's Syndrome Patients by Seror, R., Gottenberg, J. E., Devauchelle‐Pensec, V., Dubost, J. J., Le Guern, V., Hayem, G., Fauchais, A.‐L., Goeb, V., Hachulla, E., Hatron, P. Y., Larroche, C., Morel, J., Pedriger, A., Puechal, X., Rist, S., Saraux, A., Sene, D., Sibilia, J., Vittecoq, O., Zarnitsky, C., Labetoulle, M., Ravaud, P., Mariette, X.

“…Objective The European League Against Rheumatism (EULAR) Sjögren's Syndrome (SS) Disease Activity Index (ESSDAI) and the EULAR SS Patient‐Reported Index…”
Get full text

Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren’s syndrome by Gottenberg, J-E, Mignot, S, Nicaise-Rolland, P, Cohen-Solal, J, Aucouturier, F, Goetz, J, Labarre, C, Meyer, O, Sibilia, J, Mariette, X

“…Objective: To investigate the prevalence of anti-cyclic citrullinated peptide (anti-CCP) and anti-keratin antibodies (AKA) in patients with primary Sjögren’s…”
Get full text

Rituximab in the spondyloarthropathies: data of eight patients followed up in the French Autoimmunity and Rituximab (AIR) registry by Nocturne, G, Dougados, M, Constantin, A, Richez, C, Sellam, J, Simon, A, Wendling, D, Mariette, X, Gottenberg, J-E

Get more information

Correlation of serum B lymphocyte stimulator and β2 microglobulin with autoantibody secretion and systemic involvement in primary Sjögren’s syndrome by Gottenberg, J-E, Busson, M, Cohen-Solal, J, Lavie, F, Abbed, K, Kimberly, R P, Sibilia, J, Mariette, X

“…Background: In primary Sjögren’s syndrome (pSS), extraglandular involvement might result from more intense stimulation of autoreactive B cells. Thus markers of…”
Get full text

2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data‐Driven Methodology Involving Three International Patient Cohorts by Shiboski, Caroline H., Shiboski, Stephen C., Seror, Raphaèle, Criswell, Lindsey A., Labetoulle, Marc, Lietman, Thomas M., Rasmussen, Astrid, Scofield, Hal, Vitali, Claudio, Bowman, Simon J., Mariette, Xavier, Heidenreich, A. M., Lanfranchi, H., Vollenweider, C, Schiødt, M., Devauchelle, V, Gottenberg, J. E, Saraux, A, Pincemin, Maggy, Dörner, T., Tzoufias, A, Baldini, C, Bombardieri, S, De Vita, S., Kitagawa, K, Sumida, T, Umehara, H, Bootsma, H, Kruize, A. A., Radstake, T. R., Vissink, A, Jonsson, R, Ramos‐Casals, M., Theander, E, Challacombe, S, Fisher, B, Kirkham, B, Larkin, G, Ng, F, Rauz, S, Akpek, E, Atkinson, J, Baer, A. N., Carsons, S, Carteron, N, Daniels, T., Fox, B, Greenspan, J, Illei, G, Nelson, D, Parke, A, Pillemer, S, Segal, B, Sivils, K, St.Clair, E. W., Stone, D, Vivino, F, Wu, A.

“…Objective To develop and validate an international set of classification criteria for primary Sjögren's syndrome (SS) using guidelines from the American…”
Get full text